Lv3
396 积分 2023-05-30 加入
Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future
11天前
已关闭
Patients, physicians, and progress: Lessons from the history of the National Psoriasis Foundation
11天前
已关闭
Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease
3个月前
已完结
A derivative of tanshinone IIA and salviadione, 15a, inhibits inflammation and alleviates DSS-induced colitis in mice by direct binding and inhibition of RIPK2
3个月前
已完结
Discovery of Potent and Balanced Dual RIPK2 and 3 Inhibitors as a New Strategy for the Treatment of Inflammatory Bowel Diseases
3个月前
已完结
Discovery of Potent and Selective Receptor-Interacting Serine/Threonine Protein Kinase 2 (RIPK2) Inhibitors for the Treatment of Inflammatory Bowel Diseases (IBDs)
3个月前
已完结
RIP kinases as modulators of inflammation and immunity
4个月前
已完结
Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway
4个月前
已完结
DUBA sustains the stability of NOD2 and RIPK2 to enhance innate immune responses
4个月前
已完结
RIPK2 as a promising druggable target for autoimmune diseases International Immunopharmacology
4个月前
已完结
皖公网安备34019202002308
